Quantum BioPharma
@QuantumBP
Followers
6K
Following
577
Media
689
Statuses
1K
Innovating in Neurodegenerative Disease & Alcohol Health. Creators of unbuzzd™️ & Lucid-MS. Strong Execution. Diversified Treasury. NASDAQ symbol $QNTM
55 University Ave. Suite 1003
Joined June 2018
$QNTM
Lucid-MS — A Patented Multiple Sclerosis Candidate Targeting Demyelination @QuantumBP NASDAQ: QNTM / CSE: QNTM 🔵 Phase 1 trial completed with no serious adverse events 🟣 Advancing toward Phase 2 to enable next-stage clinical development
0
5
20
$QNTM
Multiple Sclerosis: A Silent Disease Affecting Millions @QuantumBP NASDAQ: QNTM / CSE: QNTM 📊 WHO estimates more than 1.8 million people worldwide live with MS 💰 Global MS therapeutics market projected to reach ~$39B by 2030 🧠 Lucid-MS, Quantum BioPharma’s lead asset, is
1
2
14
Lucid-MS: A New Path in Multiple Sclerosis | Quantum BioPharma Mouse Study Addressing Demyelination https://t.co/gpMYmNlTNy
#Multiplesclerosis #Biotech #Nasdaq #Demyelination $QNTM
2
2
15
$QNTM
Strategic Execution. Scientific Focus. Shareholder Protection. @QuantumBP NASDAQ: QNTM / CSE: QNTM ➜ Advancing Lucid-MS toward Phase 2 to address the biology of demyelination ➜ Expanding Qlarity™ in the wellness market with Health Canada approval ➜ Pursuing $700 M+
1
3
13
Today’s unbuzzd wellness Webinar Replay Can Be Found Here $QNTM https://t.co/fA4wT332Mp
webinar.mzdigital.us
Register below or visit us at https://invest.unbuzzd.com/ to start your investment today!
0
1
9
$QNTM
Over 2.8 million people live with MS — and most treatments only slow the immune attack. @QuantumBP NASDAQ: QNTM / CSE: QNTM is taking a different approach. ✅ Lucid-MS targets the process that causes nerve damage in MS (demyelination) ✅ Phase 1 safety trial completed — no
0
2
17
$QNTM
Quantum BioPharma Offers Up to $7M for Proof of Stock Manipulation @QuantumBP NASDAQ: QNTM / CSE: QNTM 💰 Up to $7 million reward for verifiable evidence of market manipulation in its shares 📜 Payable if the proof leads to a final judgment or settlement in Quantum’s $700M
0
6
21
Watch Dr. Eric Hoskins, physician & former Ontario Minister of Health and Long-Term Care, who now serves as Board Director & Medical Director at Unbuzzd wellness, as he shares insights from Unbuzzd's double-blind, placebo-controlled, crossover study. https://t.co/5Q57HMdqEk
1
3
5
$QNTM
Dear $QNTM shareholders as of record date of 27th October 2025. Please allow some time for the CVRs to show up in your accounts. The transfer agent is working on it. If by 15th of November 2025 they do not show up in your accounts then please contact your broker/Marelli for
1
4
15
Gerry David, former President & CEO of $CELH, explains why he teamed up with @getunbuzzd to bring ubuzzd to market. Quantum is proud to partner up with unbuzzd wellness $QNTM #Alcoholrecovery #Beverage #Drinks
Watch Gerry David, retired President and CEO of Celsius Holdings (Celsius Energy Drink), share why he invested early in Unbuzzd Wellness Inc. and became Board Co-Chair. https://t.co/30wIF3CpY4
@getunbuzzd @HarringtonKevin @zsaeed @DrEricHoskins @QuantumBP @ZappyZapolin
0
1
11
$QNTM Replay News release from October 2nd 2025 Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial We are pleased that we now have the final reports for these toxicity
globenewswire.com
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the...
Advancing MS Therapy on a Global Scale @QuantumBP NASDAQ: QNTM / CSE: QNTM 🧠 Lucid-MS: Patented oral therapy targeting multiple sclerosis ✅ Phase 1 safety trial completed — Phase 2 preparations underway 🌍 Regulatory and clinical preparations advancing in the U.S., U.K.,
0
3
15
$QNTM Kevin Harrington talks about unbuzzd. https://t.co/c4jxQcbKL3
Original Shark Tank Judge Backs Breakthrough Detox Drink @QuantumBP NASDAQ: QNTM / CSE: QNTM ➜ Kevin Harrington — original Shark Tank judge & “As Seen on TV” legend ➜ Invests in unbuzzd — a rising force in functional beverages 🚀 Says unbuzzd has the potential to disrupt
0
0
12
$QNTM
"I lost in excessive $500K" - Anthony Borg - QNTM Shareholder @QuantumBP NASDAQ: QNTM / CSE: QNTM ⚖️ Files $700M USD lawsuit against CIBC, RBC & others for alleged stock manipulation 📍 Case brought before the U.S. District Court, Southern District of New York 🗣️ CEO: “We’re
0
0
11
Most current therapies for Multiple Sclerosis focus on modulating the immune system to reduce inflammatory activity. Our approach takes a different path: Lucid-MS, a patented new chemical entity small molecule, is designed to target neurodegenerative pathways that contribute to
0
4
32
@getunbuzzd Follow this signup link for registration ---> https://t.co/8MYs0Ysm4n $QNTM
webinar.mzdigital.us
Register below or visit us at https://invest.unbuzzd.com/ to start your investment today!
0
0
2
Quantum BioPharma Licensee unbuzzd wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication. @getunbuzzd $QNTM #Beverage #Drinks #Alcoholrecovery
https://t.co/KffBzdVz6A
1
2
18
Learn more about Lucid-MS by visiting https://t.co/vQ9GXvQE8W $QNTM #Multiplesclerosis #Neurodegenerative #Disease #Brainhealth #Demyelination #Neurology #MSAwareness
1
4
25
Your next investment opportunity is here. Unbuzzd is hosting an investor webinar on Thurs, Oct. 30th, 4:15 pm ET. Regulation D offering & is for accredited investors only. Investment opportunity: https://t.co/zcxVhEogMW Register for webinar: https://t.co/nJuhuUI2kZ
1
3
9
Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend https://t.co/skPLYv5iYW
#QNTM $QNTM
2
4
42
Unbuzzd is clinically proven to accelerate alcohol metabolism and restore mental clarity. Backed by Celsius Energy beverage icon Gerry David and Shark Tank’s Kevin Harrington. Our Reg D offering is now open to accredited investors. https://t.co/zcxVhEogMW
0
3
7